Keyphrases
Endoplasmic Reticulum Stress (ER stress)
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Cardiac Damage
100%
Microvascular Dysfunction
100%
Growth Factor Receptor Tyrosine Kinase
100%
Streptozotocin
66%
Cardiac Fibrosis
50%
Endothelium-dependent Relaxation
50%
Insulin
33%
Kinase Phosphorylation
33%
MRNA Level
16%
C57BL
16%
Insulin Therapy
16%
Marker Expression
16%
EIF2
16%
NADPH Oxidase 4 (NOX4)
16%
NADPH Oxidase
16%
Collagen Type I
16%
Microvascular Function
16%
Diabetic Mice
16%
Tyrosine Kinase Activity
16%
Relaxation Response
16%
Plasminogen Activator inhibitor-1 (PAI-1)
16%
Activating Transcription Factor 4 (ATF4)
16%
Cardiovascular Complications
16%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
16%
NADPH Oxidase 2 (NOX2)
16%
Vascular Endothelial Dysfunction
16%
NADPH Oxidase Activity
16%
Stress Induction
16%
Activating Transcription Factor 6 (ATF6)
16%
Medicine and Dentistry
Epidermal Growth Factor Receptor
100%
Endoplasmic Reticulum Stress
100%
Heart Injury
100%
Insulin Dependent Diabetes Mellitus
100%
Streptozocin
66%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
33%
Artery Resistance
33%
Cardiovascular Disease
16%
Collagen Type 1
16%
Endothelial Dysfunction
16%
CHOP
16%
Insulin Treatment
16%
Initiation Factor 2
16%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%
Messenger RNA
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Insulin Dependent Diabetes Mellitus
100%
Heart Injury
100%
Streptozotocin
80%
Heart Muscle Fibrosis
60%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
40%
Collagen Type 1
20%
C57BL 6 Mouse
20%
Initiation Factor 2
20%
Epidermal Growth Factor Receptor Kinase Inhibitor
20%
Endothelial Dysfunction
20%
Plasminogen Activator Inhibitor 1
20%
Messenger RNA
20%
Cardiovascular Disease
20%